Abstract
You have accessJournal of UrologyPodium 32, Monday, May 21, 2007, 1:00 - 3:00 pm1 Apr 20071010: Impact of PSA Flare-Up Under the Combined Treatment with Docetaxel and Estramustine in Patients with Hormone-Refractory Prostate Cancer Thomas Nelius, Tobias Klatte, Werner de Riese, and Stephanie Filleur Thomas NeliusThomas Nelius More articles by this author , Tobias KlatteTobias Klatte More articles by this author , Werner de RieseWerner de Riese More articles by this author , and Stephanie FilleurStephanie Filleur More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)31238-2AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "1010: Impact of PSA Flare-Up Under the Combined Treatment with Docetaxel and Estramustine in Patients with Hormone-Refractory Prostate Cancer." The Journal of Urology, 177(4S), pp. 333–334 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 177Issue 4SApril 2007Page: 333-334 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Thomas Nelius More articles by this author Tobias Klatte More articles by this author Werner de Riese More articles by this author Stephanie Filleur More articles by this author Expand All Advertisement Loading ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
